A Phase 2/3 Study of TVP-1012 at 0.5 mg or 1 mg in Levodopa Treated Parkinson's Disease Participants

Clinical trial NCT02337738 · COMPLETED

Trial details

NCT number: NCT02337738
Sponsor: Takeda
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Parkinson's Disease

Start date: 2015-01-27
Primary completion: 2016-09-17
Enrollment: 404

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.